PPT-The Problem of Substandard Medicines in Developing Countries

By Laura Christian Linda Collins Maythiwan Kiatgrajai Agathe Merle Nayantara Mukherji Alissa Quade Outline Methodology Overview Definitions Harmful Effects Extent of the Problem. M ONITORING M EDICINES (FP7 G RANT N O 223566) D8 - MEDICINES OVERSEE A PILOT PROJECT AIMED AT DEVELOPMENT OF TOOLS TO IDENTIFY REPORTS INDICATING SUBSTANDARD MEDICINES G HAZALEH K HODABAKHSHI K Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Thalidomide was found to be unsafe for pregnant women as it affected their developing foetuses. Many women who took the drug gave birth to babies with severe limb deformities. . Later on Doctors discovered thalidomide could cure leprosy and started for patient suffering with the disease in the developing world. But again children were born with abnormalities.. Developed:. Higher income. Industrial economies. Slow population growth. Stronger social support systems. Ex: US, Canada, Japan, Australia & countries of western Europe. B. . Developing:. 1.Lower income. P. aul . N. e. w. t. on. . History . Definitions. Legal aspects. Impact . –. . Patient . o. utcome. Impact . –. Economy and Society. Impact . –. Resistance. Impact - Trials. A forgotten history……. Francisci. WG.8. Developed vs. Developing Countries. Indicators of Economic Development. Developed Countries. Developing Countries. 1. Availability. of natural resources (Examples: water, . oil. Gilles Forte. Policy. , Access and Use Team. Department for Essential . Medicines and Health Products. World Health Assembly Resolution 67.22 . Access . to essential medicines. Recognize . the importance of effective national medicines policies, and their . IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Once . the protection of the product . expires for . example, patents or regulatory protection such as data . exclusivity, . the company no longer has exclusive rights to sell the medicine. . Other . TRADING AWAY HEALTH: THE TRANS-PACIFIC PARTNERSHIP AGREEMENT (TPP) MSF Access Campaign Médecins Sans Frontières, Rue de Lausanne 78, CP 116, CH-1211 Geneva 21, Switzerland Tel: + 41 (0) 22 849 84 how . the pandemic has influenced the disease burden. Bengt . Jönsson. Professor emeritus, Stockholm School of Economics. Wednesday, 1 July 2020 – 16.30-19.00 CET (online event. ). Launch of the European Parliament  . Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...